Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial

Roy W Beck; Jean M Lawrence; Lori Laffel; Tim Wysocki; Dongyuan Xing; Elbert S Huang; Brett Ives; Craig Kollman; Joyce Lee; Katrina J Ruedy; William V Tamborlane; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group

doi:10.2337/dc10-0331

Back

Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial

Journal article

Open access

Peer reviewed

Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial

Roy W Beck, Jean M Lawrence, Lori Laffel, Tim Wysocki, Dongyuan Xing, Elbert S Huang, Brett Ives, Craig Kollman, Joyce Lee, Katrina J Ruedy, …

Diabetes care, Vol.33(10), pp.2175-2177

10/2010

DOI: 10.2337/dc10-0331

PMCID: PMC2945155

PMID: 20696865

Files and links (1)

url

https://doi.org/10.2337/dc10-0331View

Published (Version of record) Open Access

Abstract

To evaluate the impact of continuous glucose monitoring (CGM) on quality of life (QOL) among individuals with type 1 diabetes. In a multicenter trial, 451 children and adults with type 1 diabetes were randomly assigned to CGM treatment or the control group. Generic and diabetes-specific QOL questionnaires were completed at baseline and 26 weeks by all participants and parents of participants <18 years old, and the CGM satisfaction scale was completed by the CGM group (participants and parents) at 26 weeks. After 26 weeks, QOL scores remained largely unchanged for both the treatment and the control group, although there was a slight difference favoring the adult CGM group on several subscales (P < 0.05). There was substantial satisfaction with CGM technology after 26 weeks among participants and parents. Baseline QOL was high, and the measures showed little change with CGM use, although a high level of CGM satisfaction was reported.

Quality of Life

Hypoglycemic Agents - therapeutic use

Diabetes Mellitus, Type 1 - physiopathology

Glycated Hemoglobin A - metabolism

Humans

Diabetes Mellitus, Type 1 - metabolism

Male

Treatment Outcome

Diabetes Mellitus, Type 1 - drug therapy

Hypoglycemic Agents - pharmacology

Blood Glucose - drug effects

Young Adult

Diabetes Mellitus, Type 1 - blood

Adolescent

Adult

Female

Blood Glucose - metabolism

Details

Title: Subtitle: Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial
Creators: Roy W Beck
Jean M Lawrence
Lori Laffel
Tim Wysocki
Dongyuan Xing
Elbert S Huang
Brett Ives
Craig Kollman
Joyce Lee
Katrina J Ruedy
William V Tamborlane
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Contributors: Michael J Tansey (Contributor) - University of Iowa, Stead Family Department of Pediatrics
Resource Type: Journal article
Publication Details: Diabetes care, Vol.33(10), pp.2175-2177
DOI: 10.2337/dc10-0331
PMID: 20696865
PMCID: PMC2945155
NLM abbreviation: Diabetes Care
ISSN: 0149-5992
eISSN: 1935-5548
Grant note: K08 DK082386 / NIDDK NIH HHS
Language: English
Date published: 10/2010
Academic Unit: Endocrinology and Diabetes; Stead Family Department of Pediatrics
Record Identifier: 9984093503502771

Metrics

13 Record Views

85 Times Cited - Web of Science